Please login to the form below

Not currently logged in
Email:
Password:

Seattle Generics

This page shows the latest Seattle Generics news and features for those working in and with pharma, biotech and healthcare.

Seattle Genetics signs $2bn deal for Immunomedics' cancer drug

Seattle Genetics signs $2bn deal for Immunomedics' cancer drug

Seattle Genetics signs $2bn deal for Immunomedics' cancer drug. Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end. ... Immunomedics has signed up Seattle Genetics as the licensee for its triple-negative

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics